DRD2 and cancer: If the literature suggests that D2R antagonism could exert anti-cancer effects by inducing autophagy, apoptosis and proliferation arrest, the fact that the doses that are used in many studies are above the KD of the receptor, suggests off-target effects and more studies to get definite proofs are required.